A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women

Sexually Transmitted Diseases

Volumn 35, Issue 6, 2008, Pages 617-623

  McClelland, R Scott ^a,b   Richardson, Barbra A ^a   Graham, Susan M ^a,b   Masese, Linnet N ^a,b   Gitau, Ruth ^b   Lavreys, Ludo ^a,b   Mandaliya, Kishorchandra ^c   Jaoko, Walter ^b   Baeten, Jared M ^a   Ndinya Achola, Jeckoniah O ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; METRONIDAZOLE; PLACEBO;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYGIENE; INCIDENCE; KENYA; LABORATORY TEST; PROSPECTIVE STUDY; PROSTITUTION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEROLOGY; UNSAFE SEX; VAGINA DISCHARGE; VAGINAL PRURITUS; VAGINITIS; RISK FACTOR; SERODIAGNOSIS; SEXUALITY; VAGINAL LAVAGE;

ADULT; FEMALE; HIV SERONEGATIVITY; HUMANS; INCIDENCE; KENYA; PROSTITUTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEXUAL PARTNERS; UNSAFE SEX; VAGINAL DOUCHING; VAGINOSIS, BACTERIAL;

EID: 48049101933     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31816907fa     Document Type: Article

References (32)

1. Martin HL Jr, Nyange PM, Richarson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual trans- mission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-1059.
2. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
3. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 1998; 12:1699-1706.
4. Myer L, Denny L, Telerant R, et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: A nested case-control study. J Infect Dis 2005; 192:1372-1380.
5. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003; 36:663-668.
6. Peipert JF, Montagno AB, Cooper AS, et al. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997; 177:1184-1187.
7. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995; 333:1737-1742.
8. Ness RB, Kip KE, Soper DE, et al. Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Transm Dis 2006; 33:381-385.
9. Barbone F, Austin H, Louv WC, et al. A follow up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 1990; 163:510 -514.
10. Schwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 1999; 180: 1632-1636.
11. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 2001; 185:380-385.
12. van De Wijgert JH, Mason PR, Gwanzura L, et al. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis 2000; 181:587-594.
13. WHO. Multi-Country Study on Gender, Sexuality, and Vaginal Practices, 2007.
14. Myer L, Kuhn L, Stein ZA, et al. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: Epidemio-logical evidence and biological mechanisms. Lancet Infect Dis 2005; 5:786-794.
15. McClelland RS, Lavreys L, Hassan WM, et al. Vaginal washing and increased risk of HIV-1 acquisition among African women: A 10-year prospective study. AIDS 2006; 20:269-273.
16. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174:1058-1063.
17. McClelland RS, Richardson BA, Hassan WM, et al. Improving vaginal health in women at risk for HIV-1: Results of a randomized trial. J Infect Dis In press.
18. WHO. Guidelines for the Management of Sexually Transmitted Infections. Geneva: World Health Organization, 2003:1-91.
19. WHO, CDC. Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. Harare, Zimbabwe, 2001:1-48.
20. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
21. Eschenbach DA, Critchlow CW, Watkins H, et al. A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis Suppl 1983; 40:73-80.
22. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Intern Med 1983; 74:14-22.
23. Hutchinson KB, Kip KE, Ness RB. Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Sex Transm Dis 2007; 34:671-675.
24. Hassan WM, Lavreys L, Chohan V, et al. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Sex Transm Dis 2007; 34:384-388.
25. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486.
26. Marrazzo JM. A persistent(ly) enigmatic ecological mystery: Bacterial vaginosis. J Infect Dis 2006; 193:1475-1477.
27. Riggs M, Klebanoff M, Nansel T, et al. Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis 2007; 34:954-959.
28. Ildgruben AK, Sjoberg IM, Hammarstrom ML. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet Gynecol 2003; 102:571-582.
29. Belsey EM. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 1988; 38:181-206.
30. Anukam KC, Osazuwa EO, Ahonkhai I, et al. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis 2006; 33:59-62.
31. Fredricks DN, Fiedler TN, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 355:1899-1911.
32. McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: A 10-year prospective study. J Infect Dis 2005; 191:333-338.